Siemens’ tomosynthesis add-on lands FDA approval

The FDA has approved the breast tomosynthesis add-on option for Siemens Healthcare’s MAMMOMAT Inspiration and MAMMOMAT Inspiration Prime Edition digital mammography systems.

Siemens’ tomosynthesis algorithm takes 25 projections, acquired as the digital mammography system rotates in a circular motion with an angular range of 50 degrees, and reconstructs them as a 3D digital breast tomosynthesis image.

Studies have shown that adding tomosynthesis to digital mammography can decrease recall rates and increase cancer detection.

The MAMMOMAT Inspiration with Tomosynthesis Option has been commercially available since 2009 in Europe, Asia and South America, according to Siemens.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.